There are a number of prostate cancer treatments to consider. Each type brings different benefits and risks so it’s important to be informed and make a decision based on what’s best for you. The most significant disadvantages revolve around potential side effects of the chosen option. Talk to your doctor about advice on treatments and lifestyle changes.
By choosing active surveillance, you are delaying or avoiding altogether the immediate and life-changing side effects of surgery, radiation therapy or other treatments.
Is Oncotype DX for you?
Are you a newly diagnosed prostate cancer patient or family member who is trying to determine what treatment plan is right for you or your loved one?
See the quiz
Get Questions to Ask Your Doctor
Learn more about Oncotype DX and read prostate cancer patient stories right in your inbox
Load video here.
The information presented on this site is intended to provide patients with newly diagnosed prostate cancer, as well as their friends and family, an opportunity to learn how the information provided by the Oncotype DX Genomic Prostate Score can be used, along with other clinical measures, to help patients and their doctors make treatment decisions. Patients should consult their doctor to determine the best treatment decision for their individual disease.
National Comprehensive Cancer Network (NCCN) and NCCN are registered trademarks of NCCN. NCCN does not endorse any product or therapy.
Copyright © 2013-2018 Genomic Health, Inc. All rights reserved. Genomic Health, Oncotype, and Oncotype DX are trademarks, and Genomic Prostate Score is a pending registered trademark of Genomic Health Inc. MyProstateCancerTreatment.org is sponsored by Genomic Health, Inc., a clinical laboratory in Redwood City, California that developed and offers the Oncotype DX Prostate Cancer Assay. Genomic Health is responsible for the content of MyProstateCancerTreatment.org.